A 35-year-old pregnant woman presents to the emergency department with progressive dyspnea and palpitations that have worsened during the last 3 weeks.
The FDA has released draft guidance documents for appropriate marketing communication on medical products and devices.
Learn about the comprehensive management of rheumatic heart disease with Jack Boyd, MD, clinical assistant professor of cardiothoracic surgery at Stanford University School of Medicine.
While mortality rates were similar between percutaneous coronary intervention and coronary artery bypass grafting in both EXCEL and NOBLE trials, the risk of major cardiovascular events was higher in PCI in NOBLE.
Experts say bioresorbable stents are "a few generations away" from being standard of care in interventional cardiology.
A composite end point of death, heart failure, new myocardial infarction, and revascularization was similar between the deferred stenting group and the conventional treatment group.
An overview of the groundbreaking technology that has shaped interventional cardiology.
Transcatheter aortic valve replacement continues to evolve as a treatment for patients with symptomatic severe aortic stenosis, as well as for younger, lower-risk patients.
In patients with COPD, transcatheter aortic valve replacement was associated with fewer respiratory-related complications than surgical aortic valve replacement.
Major adverse cardiovascular events were not reduced in patients with acute coronary syndrome undergoing planned percutaneous coronary intervention when given 2 loading doses of atorvastatin.
Aim of study was to determine whether treatment with percutaneous coronary intervention or coronary artery bypass grafting leads to improved outcomes in patients with diabetes, coronary artery disease, and left ventricular dysfunction.
The smartphone heart rate monitoring application had higher diagnostic accuracy compared with standard physical examination for determining ulnar artery patency prior to radial access.
Patients with pulmonary hypertension have a high risk for adverse events during and following cardiac catheterization, but high case volume may help ameliorate this risk.
Patent foramen ovale closure resulted in a lower recurrence of stroke in patients with cryptogenic stroke and high-risk PFO characteristics.
The FDA has approved a new size of the Masters Series Mechanical Heart Valve with Hemodynamic Plus Sewing Cuff for use in newborn patients with heart defects.
Abnormal glucose metabolism may be present in patients with undetected diabetes after percutaneous coronary intervention.
A shared decision-making program between patients with end-stage heart failure being considered for destination therapy left ventricular assist device and their caregivers was associated with improvement in patient knowledge.
Percutaneous closure of patent foramen ovale is not associated with a reduction in migraine headaches in patients with and without aura.
The Cardiology Advisor Articles
- The Mounting Evidence Against Electronic Cigarette Use
- Entresto Significantly Improves Physical, Social Activity in Heart Failure Patients
- Oxygen Therapy in Acute MI Not Associated With Clinical Benefit
- Nonpsychotic Cannabinoids in Hypertension: Benefits and Harms
- ACC and AHA Release 2018 Quality Measures for Cardiac Rehabilitation